Navigation Links
Champions Oncology Reports Financial Results for the Quarter Ended October 31, 2012
Date:12/13/2012

ties and other factors.  Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Oncology's future results, levels of activity, performance or achievements may not meet these expectations.  The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Oncology's expectations, except as required by law.

Contact:
Susan Foreman
410-369-0365
sforeman@championsoncology.com Champions Oncology, Inc.
(Dollars in thousands except per share amounts)Reconciliation of GAAP to Non-GAAP Net LossThree Months Ended October 31,Six Months Ended October 31,2012201120122011Net loss – GAAP

($1,974)

($2,349)

($3,297)

($4,387)Less:

624

855

1,364

1,868  Stock-based compensationNet loss - non-GAAP

($1,350)

($1,494)

($1,933)

($2,519) Reconciliation of GAAP to Non-GAAP Earnings Per Share (EPS)Three Months Ended October 31,Six Months Ended October 31,2012201120122011EPS – GAAP

($0.04)

($0.05)

($0.07)

($0.09)Less:

0.01

0.02

0.03

0.04Effect of stock-based compensation on EPSEPS - non-GAAP

($0.03)

($0.03)

($0.04)

($0.05) Condensed Consolidated Statements of Operations (Unaudited)Three MonthsEnded October 31,Six MonthsEnded October 31,2012201120122011POS operating revenue

$459

$590

$1,377

$1,188TOS operating revenue

999

1,151

2,187

2,184  Total operating revenue$1,458$1,741$3,564$3,372Cost of POS

582

461


'/>"/>
SOURCE Champions Oncology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities
2. Champions Oncology Reports Financial Results for the Year Ended April 30, 2012
3. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
4. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
5. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
6. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
7. 500 Oncology Providers Sign Up for Navigating Cancers Patient Engagement Portal
8. Symphogen Grants Exclusive Worldwide License of Phase II Oncology Drug Candidate Sym004 to Merck KGaA
9. New Boehringer Ingelheim Oncology Data to be Presented at ESMO 2012 Congress
10. International Oncology Innovators Meeting in Hamburg
11. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013   Flexion Therapeutics , ... W. Driscoll to its management team as ... years of financial management experience with biotechnology and medical ... Driscoll was chief financial officer for Novavax (NASDAQ: ... secured more than $250 million through a combination of ...
(Date:5/20/2013)... On 25-28 July, 2013, UPCP 2013 ... - the beautiful city of lights. , According to ... revolutionizing the medical world. Understanding and integrating genetic and ... of this transformation. Much of the present medical practice ... studies of large cohorts that do not take into ...
(Date:5/19/2013)... 2013 The JM Internet Group (web: ... has proudly announced that the company's YouTube channel on ... 175,000 views on YouTube. The company uses YouTube as ... tips and training for small businesses with much success. ... YouTube tips helpful for their SEO strategies", explained Jason ...
(Date:5/17/2013)... news release is available in German . ... too well: with the naked eye, you can see which ... in the blur of branches through the telephoto lens for ... for researchers who are looking to study proteins, the active ... ETH Zurich,s Institute for Molecular Systems Biology, and her colleagues ...
Breaking Biology Technology:Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris 2YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3
... the Wisconsin Alumni Research Foundation's European stem ... , ,The foundation's stem cell patent is controversial enough ... overly broad and is suppressing scientific research. While that ... than 300 academic licenses it has issued for stem ...
... is entering a new phase. Both are headed to a jumpsuit ... years but the ex-heads of Enron - Ken Lay and Jeff ... thoroughly non-gullible jury of their fellow Houstonians. The duo will soon ... their crimes. , , When Creative Becomes Criminal ...
... always taken for granted was the quality of sound on ... emphasized that "you can hear a pin drop" as they ... ,The old Bell system also had very stringent requirements for ... digital lines with digital repeaters (amplifiers) that actually regenerated the ...
Cached Biology Technology:WARF stem cell patent faces long and winding road 2WARF stem cell patent faces long and winding road 3WARF stem cell patent faces long and winding road 4WARF stem cell patent faces long and winding road 5Are there more Enrons out there? 2Are there more Enrons out there? 3Are there more Enrons out there? 4Is traditional voice quality an oxymoron with today's cellular, VoIP? 2Is traditional voice quality an oxymoron with today's cellular, VoIP? 3
(Date:5/17/2013)... A new Dartmouth College study finds human-caused climate ... of tropical lizards, contradicting a host of recent ... rapidly warming planet. , The findings, which appear ... offer new hope for survival of a creature ... Most predictions that tropical cold-blooded animals, especially forest ...
(Date:5/16/2013)... MARC (Maximizing Access to Research Careers) Program has ... Society (ENDO) 95th Annual Meeting in San Francisco, ... meant to promote the entry of students, postdoctorates ... of the basic science community and to encourage ... 2013 Annual Meeting. , Awards are given to ...
(Date:5/16/2013)... University scientists have shown a gene involved in neurodegenerative ... function of the circadian clock. , In a ... the gene, called Ataxin-2, keeps the clock responsible for ... gene, the rhythm of the fruit fly,s sleep-wake cycle ... difficult for the fly. , The discovery is ...
Breaking Biology News(10 mins):Climate change may have little impact on tropical lizards 2Gene involved in neurodegeneration keeps clock running 2
... - the idea of using genetic instructions rather than drugs ... but is not yet a viable therapeutic method. One ... place at the right time. , Engineers at the University ... problem. David M. Lynn and his colleagues have created ...
... hit all his developmental landmarks but after his first birthday he ... infection. He stopped eating and was no longer happy and playful. ... at us anymore; he was in his own little world. At ... and was smearing (feces) on the walls. My baby had been ...
... the urgent need for alternative energy, Florida Tech ... a $430,000 contract from Aurora Biofuels for large-scale ... so far is in small-scale cultivation. , Lin ... Vero Beach Marine Laboratory. His work is to ...
Cached Biology News:Ultrathin films deliver DNA as possible gene therapy tool 2Ultrathin films deliver DNA as possible gene therapy tool 3Army research mission focused on autism 2Army research mission focused on autism 3Army research mission focused on autism 4
Human SOST Affinity Purified Polyclonal Ab...
(3-[125I]iodotyrosyl26)Galanin, porcine, 370 kBq, 10 uCi. Category: IODINE LIGANDS....
(3-[125I]iodotyrosyl26)Galanin (porcine), 925 kBq, 25 uCi. Category: IODINE LIGANDS....
Human Legumain Affinity Purified Polyclonal Ab...
Biology Products: